Friday 2 December 2016

In-Depth Study on Tissue Sealants - Medical Devices Pipeline Assessment, 2016

Tissue Sealants - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Tissue Sealants currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Sealants pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
To access full report with TOC, please visit Tissue Sealants - Medical Devices Pipeline Assessment, 2016
Scope
- Extensive coverage of the Tissue Sealants under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Sealants under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Advanced Medical Solutions Group plc Argon Medical Devices Inc. Baxter International Inc Biomedica Management Corp Boston University C. R. Bard Inc Calmare Therapeutics Inc Clemson University Cohera Medical, Inc. Covalent Medical, Inc. DSM Biomedical B.V. Emory University Ethicon Endo-Surgery, Inc. Gamma Therapeutics Inc Gecko Biomedical Grifols SA Hemostasis, LLC HyperBranch Medical Technology, Inc. InVivo Therapeutics Corporation John Hopkins University Kollodis BioSciences, Inc. Kuros Biosciences AG LifeBond Ltd. Medical Adhesive Revolution GmbH Medisse BV OptMed, Inc. Pharming Group NV Polyganics B.V. Protein Polymer Technologies Inc Sea Run Holdings Inc Sealantis Ltd. Shanghai Haohai Biological Technology Co., Ltd. Surgical Sealants, Inc. Teijin Pharma Ltd Texas A&M University The Medicines Company University of Akron
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home